Search by Drug Name or NDC

    NDC 69423-0999-12 Vicks NyQuil 10; 6.25; 5 mg/15mL; mg/15mL; mg/15mL Details

    Vicks NyQuil 10; 6.25; 5 mg/15mL; mg/15mL; mg/15mL

    Vicks NyQuil is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by The Procter & Gamble Manufacturing Company. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 69423-0999
    Product ID 69423-999_07d66fb2-f4d0-479c-e063-6394a90a5e91
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Vicks NyQuil
    Proprietary Name Suffix Cough DM plus Congestion
    Non-Proprietary Name Dextromethorphan Hydrobromide, Doxylamine succinate and Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 10; 6.25; 5
    Active Ingredient Units mg/15mL; mg/15mL; mg/15mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name The Procter & Gamble Manufacturing Company
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 69423-0999-12 (69423099912)

    NDC Package Code 69423-999-12
    Billing NDC 69423099912
    Package 354 mL in 1 BOTTLE, PLASTIC (69423-999-12)
    Marketing Start Date 2020-07-08
    NDC Exclude Flag N
    Pricing Information N/A